palbociclib 100 MG Oral Tablet [Ibrance]

RxCUI
2284104
RxNorm name
palbociclib 100 MG Oral Tablet [Ibrance]
Display name
palbociclib 100 MG Oral Tablet [Ibrance]
Full name
palbociclib 100 MG Oral Tablet [Ibrance]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IbrancePALBOCICLIBU.S. Pharmaceuticals89a142d5-7e61-48bf-9e77-e2cd124c47922026-07-06Warnings, Adverse reactionsExact identifier
rxcui: 2284104
IbrancePALBOCICLIBPfizer Laboratories Div Pfizer Incfecbdd7d-b729-41b5-9872-231b8fe104ce2026-07-02Warnings, Adverse reactionsExact identifier
rxcui: 2284104

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fecbdd7d-b729-41b5-9872-231b8fe104cepalbociclib 100 MG Oral Tablet [Ibrance]SBD12These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260225
fecbdd7d-b729-41b5-9872-231b8fe104ceIbrance 100 MG Oral TabletSY12These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260225
fecbdd7d-b729-41b5-9872-231b8fe104ceIbrance 100 MG Oral TabletPSN12These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260225
89a142d5-7e61-48bf-9e77-e2cd124c4792palbociclib 100 MG Oral Tablet [Ibrance]SBD10These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260530
89a142d5-7e61-48bf-9e77-e2cd124c4792Ibrance 100 MG Oral TabletPSN10These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260530
89a142d5-7e61-48bf-9e77-e2cd124c4792Ibrance 100 MG Oral TabletSY10These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260530